{"id":"https://genegraph.clinicalgenome.org/r/9765e465-ccdd-43bd-b059-3f3dcef4403cv1.1","type":"EvidenceStrengthAssertion","dc:description":"*CFAP418* (previously known as *C8orf37*) was first reported in relation to autosomal recessive Bardet Biedl syndrome in 2012 (Estrada-Cuzcano et al., PMID: 22177090). BBS is a rare genetically heterogeneous ciliopathy, characterized by rod-cone dystrophy, polydactyly, obesity, genital anomalies, renal anomalies, and intellectual disabilities. Additional families have affected members diagnosed with conditions such as retinitis pigmentosa or cone-rod dystrophy (PMID: 22177090, PMID: 25802487). Per criteria outlined by the ClinGen Lumping & Splitting Working Group, the mode of inheritance (autosomal recessive) and molecular mechanism (biallelic *CFAP418* disruption) were found to be consistent among patients diagnosed with Bardet-Biedl syndrome 21 (MIM# 617406), cone-rod dystrophy 16 (MIM# 614500), or retinitis pigmentosa 64 (MIM# 614500). The phenotypic variability between cases appears to represent a spectrum of disease rather than separate disease entities. Therefore, cases caused by inherited biallelic *CFAP418* variants have been lumped into a single disease entity, referred to as CFAP418-related ciliopathy.\n\nThis curation includes eight variants (three canonical splicing, two missense, and three nonsense) that have been reported in nine probands in five publications (PMIDs: 22177090, 25802487, 27008867, 26854863, 26865426). The mechanism of pathogenicity is likely to be biallelic loss-of-function.\n\nThis gene-disease association is also supported by an expression study showing that *CFAP418* is highly expressed in the retina, as well as localized at base of the photoreceptor connecting cilia and photoreceptor inner segments (PMID: 22177090). Using a zebrafish model with knockdown of the *CFAP418* ortholog, Heon et. al. show that the Kuppfer’s vesicle (a ciliated organ) of mutant zebrafish is smaller and has reduced cilia content compared to wild-type fish. Overexpressing the p.Arg177Trp or p.Gln182Arg variants in *CFAP418* results in Kuppfer’s vesicle defects and visual impairment (PMID: 27008867). Finally, a *CFAP418* knockout mouse model shows reduced scotopic and photopic ERG responses, progressive retinal degeneration, and a reduction in outer segment protein expression in the retina (PMID: 29440555).\n\nIn summary, *CFAP418* is definitively associated with autosomal recessive CFAP418-related ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time without the emergence of contradictory evidence. This classification was approved by the ClinGen Retina Gene Curation Expert Panel on July 11, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/9765e465-ccdd-43bd-b059-3f3dcef4403c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/791b95ad-3c89-436c-aa6e-c153c1c1ea61","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/791b95ad-3c89-436c-aa6e-c153c1c1ea61_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-07-11T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/791b95ad-3c89-436c-aa6e-c153c1c1ea61_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2024-10-01T01:08:28.525Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/791b95ad-3c89-436c-aa6e-c153c1c1ea61_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e6de49f-13d9-4e2a-a817-2f82befce9fe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e6de49f-13d9-4e2a-a817-2f82befce9fe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","rdfs:label":"Estrada-Cuzcano_Family2_V1","allele":{"id":"https://genegraph.clinicalgenome.org/r/804e5995-8096-438c-879a-eb926209ed69","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.156-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371837717"}},"detectionMethod":"SNP array","firstTestingMethod":"Other","phenotypeFreeText":"postaxial polydactyly at birth, RP with age of onset in teens","previousTesting":true,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/56ce3990-2b12-4668-8e84-6343d61cf1cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","allele":{"id":"https://genegraph.clinicalgenome.org/r/804e5995-8096-438c-879a-eb926209ed69"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/56ce3990-2b12-4668-8e84-6343d61cf1cd","type":"EvidenceLine","dc:description":"scored reduced due to lack of WES","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56ce3990-2b12-4668-8e84-6343d61cf1cd_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5cf8f7e1-0a53-4851-8dd7-eb61de6c30e5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cf8f7e1-0a53-4851-8dd7-eb61de6c30e5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25802487","rdfs:label":"Ravesh_MA13_863","allele":{"id":"https://genegraph.clinicalgenome.org/r/db2b9b85-6b91-4f1a-95a6-6915c68ffbd4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.555G>A (p.Trp185del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4815113"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"RP but no other BBS symptoms","previousTesting":true,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1287ea82-5880-4d1a-aea9-ed4ba3c5a496_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25802487","allele":{"id":"https://genegraph.clinicalgenome.org/r/db2b9b85-6b91-4f1a-95a6-6915c68ffbd4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/1287ea82-5880-4d1a-aea9-ed4ba3c5a496","type":"EvidenceLine","dc:description":"variant is nonsense but is in final exon so NMD not expected","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1287ea82-5880-4d1a-aea9-ed4ba3c5a496_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/84f28572-62c6-4a0c-868b-991a01f8a3dd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84f28572-62c6-4a0c-868b-991a01f8a3dd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25802487","rdfs:label":"Ravesh_MA48_48-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7b36f44-7353-42f1-bf96-167dd2573d33","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.244-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16616877"}},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"RP","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/93490f40-6d1f-489d-873e-5d4a93fd2d91_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25802487","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7b36f44-7353-42f1-bf96-167dd2573d33"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/93490f40-6d1f-489d-873e-5d4a93fd2d91","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93490f40-6d1f-489d-873e-5d4a93fd2d91_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/93490f40-6d1f-489d-873e-5d4a93fd2d91_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A minigene splicing assay using HEK293 cells showed that the splice-site mutation activates a cryptic splice site within exon 3, causing a 22 bp deletion in the transcript that predicts a frameshift and premature termination of protein translation (Figures 3C,D).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/3b343267-f1aa-4085-9313-c0f670a273b7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b343267-f1aa-4085-9313-c0f670a273b7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","rdfs:label":"Estrada-Cuzcano_Family1_IV:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/63a8288e-c278-453e-9c7f-274c68185f35","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.497T>A (p.Leu166del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371838342"}},"detectionMethod":"SNP array","firstTestingMethod":"Other","phenotypeFreeText":"RP, no other BBS symptoms mentioned","previousTesting":true,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/46f8d983-9ffa-4724-aba1-b27491c41157_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","allele":{"id":"https://genegraph.clinicalgenome.org/r/63a8288e-c278-453e-9c7f-274c68185f35"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/46f8d983-9ffa-4724-aba1-b27491c41157","type":"EvidenceLine","dc:description":"variant is in final exon, not expected to result in NMD","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46f8d983-9ffa-4724-aba1-b27491c41157_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/94b7b1ad-7eff-4c0d-84f5-4690d8dfe694_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94b7b1ad-7eff-4c0d-84f5-4690d8dfe694","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26854863","rdfs:label":"Khan_Case1","allele":{"id":"https://genegraph.clinicalgenome.org/r/50630df6-3d9b-4b9b-9ed4-e7f67c5701cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.529C>T (p.Arg177Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA260013"}},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"RP + Postaxial polydactyly","previousTesting":true,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0af1cda3-c834-4c8c-bfc4-ddeed112e8a5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26854863","allele":{"id":"https://genegraph.clinicalgenome.org/r/50630df6-3d9b-4b9b-9ed4-e7f67c5701cb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/0af1cda3-c834-4c8c-bfc4-ddeed112e8a5","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0af1cda3-c834-4c8c-bfc4-ddeed112e8a5_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c1d8adb6-ac7d-47be-be21-ad64ae5fdbc6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1d8adb6-ac7d-47be-be21-ad64ae5fdbc6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27008867","rdfs:label":"Heon_Case1","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5ca869d-f5ec-4817-9ac5-f99888c5166a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.304A>T (p.Lys102del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4815195"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"RP, The patient was overweight (with a body mass index of 29.1 at 15 years) and had three limbs post-axial polydactyly, a horseshoe kidney (with normal function), mild learning difficulty and elevated liver enzymes (alanine transaminase: 81 units/l). ","previousTesting":true,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/40ad49a8-a341-476f-b2dc-1ed62e8e77e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27008867","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5ca869d-f5ec-4817-9ac5-f99888c5166a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/40ad49a8-a341-476f-b2dc-1ed62e8e77e8","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40ad49a8-a341-476f-b2dc-1ed62e8e77e8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/40ad49a8-a341-476f-b2dc-1ed62e8e77e8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Semi-quantitative analysis of RT-PCR to assess the role of NMD. Products are cDNAs derived from lymphoblast cell lines from the patient with the variant c.304A> T and a WT individual for the c.304 position. The effect of treatments with cycloheximide (CHX) and dimethyl sulfoxide (DMSO) show that c.304>T undergoes NMD. Figure 1C","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/598540de-361b-48ef-bd9f-898630a8e7d4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/598540de-361b-48ef-bd9f-898630a8e7d4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","rdfs:label":"Estrada-Cuzcano_Family4_IV:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/047191e0-4daf-4733-bacc-a8d4a55845db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.545A>G (p.Gln182Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129739"}},"detectionMethod":"snp array","firstTestingMethod":"Other","phenotypeFreeText":"RP","previousTesting":true,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9858984b-04da-4b6f-915d-6d655291882c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","allele":{"id":"https://genegraph.clinicalgenome.org/r/047191e0-4daf-4733-bacc-a8d4a55845db"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/9858984b-04da-4b6f-915d-6d655291882c","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9858984b-04da-4b6f-915d-6d655291882c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/cead5b61-8794-496f-85a9-55f4b3e5e962_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cead5b61-8794-496f-85a9-55f4b3e5e962","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","rdfs:label":"Estrada-Cuzcano_Family3_IV:2","allele":{"id":"https://genegraph.clinicalgenome.org/r/50630df6-3d9b-4b9b-9ed4-e7f67c5701cb"},"detectionMethod":"snp array","firstTestingMethod":"Other","phenotypeFreeText":"RP","previousTesting":true,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8a88f71a-b833-479f-ab6d-3e41dc2b2711_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","allele":{"id":"https://genegraph.clinicalgenome.org/r/50630df6-3d9b-4b9b-9ed4-e7f67c5701cb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/8a88f71a-b833-479f-ab6d-3e41dc2b2711","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a88f71a-b833-479f-ab6d-3e41dc2b2711_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/7ec3f784-e5b4-40a7-9324-b95cb303ebac_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ec3f784-e5b4-40a7-9324-b95cb303ebac","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26865426","rdfs:label":"Rahner_Family2_II:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/842afc10-0d5d-4b77-a0bc-e894c5588c70","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177965.4(CFAP418):c.155+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371837725"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"RP + postaxial polydactyly","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d16876f9-f635-4e2d-8a64-16fddc01b7cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26865426","allele":{"id":"https://genegraph.clinicalgenome.org/r/842afc10-0d5d-4b77-a0bc-e894c5588c70"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/d16876f9-f635-4e2d-8a64-16fddc01b7cf","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d16876f9-f635-4e2d-8a64-16fddc01b7cf_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d16876f9-f635-4e2d-8a64-16fddc01b7cf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Figure 3A shows an abscence of a 618 bp product in homozygous family members with the mutation","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/791b95ad-3c89-436c-aa6e-c153c1c1ea61_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/791b95ad-3c89-436c-aa6e-c153c1c1ea61_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3d837c7-afba-4f24-8795-efbeb93c964f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5e49f83-9903-4d92-9498-f7fcf77b560c","type":"Finding","dc:description":"In adult human tissues, C8orf37 is expressed ubiquitously and there are high levels of mRNA expression in the brain, heart, and retinae (Figure 3A). Additionally, immunolocalization studies using hTERT-RPE1 cells and postnatal day 30 mouse retinal sections show C8orf37 staining at the base of the photoreceptor connecting cilia and photoreceptor inner segments. This is relevent for this disease as Bardet Biedl Syndrome is a known syndromic ciliopathy. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22177090","rdfs:label":"Estrada-Cuzcano_Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9b903855-7462-4ed6-a822-ba22f12bb927","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/515892b1-6266-4ea6-b1b9-9060e84a39d4","type":"Finding","dc:description":"FAM161A, a microtubule-binding protein localized at the photoreceptor cilium is required for photoreceptor survival. Double immunofluorescence staining and proximity ligation assay (PLA) of marmoset retinal sections and in HEK-293 cells showed that C8orf37 was  co-localized with FAM161A at the ciliary base of photoreceptors. Furthermore, interaction domain mapping assays identified that the N-terminal region of C8orf37 and amino acid residues 341-517 within the PFAM UPF0564 domain of FAM161A were critical for C8orf37–FAM161A interaction. These data suggest that the two photoreceptor survival proteins, C8orf37 and FAM161A, interact with each other which may contribute to photoreceptor health.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36233334","rdfs:label":"Liu_Protein_Interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/791b95ad-3c89-436c-aa6e-c153c1c1ea61_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc12787a-abf3-4430-a13f-2c241d021a2b","type":"EvidenceLine","dc:description":"mutant zebrafish only recapitulate a subet of the major BBS symptoms","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ae83b3f-8ed8-4597-981a-924f55169f25","type":"Finding","dc:description":"The zebrafish model recapitulates a subset of the symptoms seen in human BBS patients, mainly defects in ciliary function and decrease in startle respone in mutant zebrafish compared to controls. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27008867","rdfs:label":"Heon_Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/94bc696a-01ed-4a87-be75-b0be6316ddf0","type":"EvidenceLine","dc:description":"No polydactyly or obesity are observed in KO mice compared to heterozygous littermates","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68c43b64-27ce-4f69-bfb0-fc1d44f8edf9","type":"Finding","dc:description":"C8orf37 KO mice have reduced scotopic and photopic ERG responses, C8orf37del/del mice and progressive retinal degeneration as measured by SD-OCT. Additionally, immunoblot assays show that many OS proteins are reduced in retinas of KO mice. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29440555","rdfs:label":"Sharif_KO_Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":9095,"specifiedBy":"GeneValidityCriteria10","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/HS0xYB-tlzs","type":"GeneValidityProposition","disease":"obo:MONDO_0005308","gene":"hgnc:27232","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_791b95ad-3c89-436c-aa6e-c153c1c1ea61-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}